Heart disease and stroke statistics—2022 update: a report from the American Heart Association
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Heart disease and stroke statistics—2023 update: a report from the American Heart Association
CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson… - Circulation, 2023 - Am Heart Assoc
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association
BACKGROUND: The American Heart Association (AHA), in conjunction with the National
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …
Empagliflozin reduced mortality and hospitalization for heart failure across the spectrum of cardiovascular risk in the EMPA-REG OUTCOME trial
D Fitchett, SE Inzucchi, CP Cannon, DK McGuire… - Circulation, 2019 - Am Heart Assoc
Background: In the EMPA-REG OUTCOME trial (BI 10773 [Empagliflozin] Cardiovascular
Outcome Event Trial in Type 2 Diabetes Mellitus Patients) in patients with type 2 diabetes …
Outcome Event Trial in Type 2 Diabetes Mellitus Patients) in patients with type 2 diabetes …
Heart disease and stroke statistics—2020 update: a report from the American Heart Association
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports on the most up-to-date statistics related to heart disease, stroke …
Health, annually reports on the most up-to-date statistics related to heart disease, stroke …
[HTML][HTML] Heart disease and stroke statistics-2021 update: a report from the American Heart Association.
Background The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Cluster analysis of cardiovascular phenotypes in patients with type 2 diabetes and established atherosclerotic cardiovascular disease: a potential approach to …
A Sharma, Y Zheng, JA Ezekowitz… - Diabetes …, 2022 - Am Diabetes Assoc
OBJECTIVE Phenotypic heterogeneity among patients with type 2 diabetes mellitus (T2DM)
and atherosclerotic cardiovascular disease (ASCVD) is ill defined. We used cluster analysis …
and atherosclerotic cardiovascular disease (ASCVD) is ill defined. We used cluster analysis …
Predicting 10-year risk of end-organ complications of type 2 diabetes with and without metabolic surgery: a machine learning approach
A Aminian, A Zajichek, DE Arterburn, KE Wolski… - Diabetes …, 2020 - Am Diabetes Assoc
OBJECTIVE To construct and internally validate prediction models to estimate the risk of
long-term end-organ complications and mortality in patients with type 2 diabetes and obesity …
long-term end-organ complications and mortality in patients with type 2 diabetes and obesity …
Environmental noise exposure is associated with atherothrombotic risk
M Koczorowski, N Bernard, F Mauny, F Chagué… - Scientific Reports, 2022 - nature.com
There is growing evidence that environmental noise exposure could increase the risk of
atherothrombotic events, including acute myocardial infarction (MI). We analysed the burden …
atherothrombotic events, including acute myocardial infarction (MI). We analysed the burden …
Predictive models for cardiovascular and kidney outcomes in patients with type 2 diabetes: systematic review and meta-analyses
TA Buchan, A Malik, C Chan, J Chambers, Y Suk… - Heart, 2021 - heart.bmj.com
Objective To inform a clinical practice guideline (BMJ Rapid Recommendations) considering
sodium glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists for …
sodium glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists for …